BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 10098493)

  • 1. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
    Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S; Ban T; Kohn LD
    Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
    Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
    J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
    Kim WB; Cho BY; Park HY; Lee HK; Kohn LD; Tahara K; Koh CS
    J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance.
    Kohn LD; Harii N
    Autoimmunity; 2003; 36(6-7):331-7. PubMed ID: 14669940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy.
    Wortsman J; McConnachie P; Tahara K; Kohn LD
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2302-8. PubMed ID: 9661599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of TSH receptor antibodies in thyroid diseases.
    Cho BY
    J Korean Med Sci; 2002 Jun; 17(3):293-301. PubMed ID: 12068130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.
    Kosugi S; Ban T; Akamizu T; Valente W; Kohn LD
    J Clin Endocrinol Metab; 1993 Jul; 77(1):19-24. PubMed ID: 8100829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the peptides that inhibit the function of human monoclonal thyroid-stimulating antibodies from phage-displayed peptide library.
    Byun CH; Park JY; Akamizu T; Chae CB
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3311-8. PubMed ID: 11443206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
    Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
    Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications.
    Kim WB; Chung HK; Lee HK; Kohn LD; Tahara K; Cho BY
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1953-9. PubMed ID: 9177413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.